amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
| Name | E4_AMYL_SCNDSYST |
|---|---|
| Long name | Secondary systemic amyloidosis |
| Hospital Discharge registry | ICD-10: E853 |
| Cause of Death registry | ICD-10: E853 |
| Level in the ICD-hierarchy | 4 |
| First defined in version | DF2 |
| Latin name | Amyloidosis systemica secundaria |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 46 | 31 | 15 |
| Unadjusted prevalence (%) | 0.02 | 0.03 | 0.02 |
| Mean age at first event (years) | 60.39 | 59.41 | 62.41 |
| Case fatality at 5-years (%) | 34.78 | 38.71 | 26.67 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 3.0 | 3.0 | 3.0 |
| Recurrence at 6 months (%) | 52.17 | 48.39 | 60.00 |
before Secondary systemic amyloidosis
after Secondary systemic amyloidosis
Loading survival analyses plot…
Loading survival analyses table…